Lumida
/AVNT
⌘K
Avient Corp

Avient Corp

AVNT
$41.41USD↓-0.74%-0.31 today

MARKET CAP

3.8B

P/E (TTM)

24.1x

FWD P/E

—

DAY RANGE

$41 – $42

52W RANGE

$27
$47

AI Summary

Stalk
Sell NowMedium

The stock is in a Stage 4 decline with a clear series of lower highs and lower lows. Price is trading below the 9- and 20-day EMAs, rolling off with each attempted rally and approaching the 50-day SMA as potential interim support. Medium-term bias is bearish, and near-term timing favors selling into rallies toward the short EMA stack. We look to sell on rejection at the EMAs or a failure to hold the 50-day SMA.

  • ↑FY23 revenue $30.2M (+33% YoY); Adjusted EBITDA $4.4M (+132% YoY).
  • ↑Q3 production 3,268 kg (+61% YoY) after Flower Group integration.
  • ↓Recreational sales decline noted by management could hinder revenue momentum.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Avant Brands Inc. (CSE: AVNT) is a prominent player in the Canadian cannabis industry, specializing in the cultivation and distribution of premium cannabis products. The company focuses on both domestic and international markets, actively expanding its presence through strategic acquisitions, such as the Flower Group, which significantly enhances its production capacity. Avant's brand, Black Market, has established a strong reputation for quality amidst growing competition and evolving consumer preferences. The company is positioned to leverage opportunities within the cannabis landscape, particularly as it navigates the transition towards greater export sales amidst challenging domestic market conditions.

Bull says

  • ↑FY23 revenue $30.2M (+33% YoY); Adjusted EBITDA $4.4M (+132% YoY).
  • ↑Q3 production 3,268 kg (+61% YoY) after Flower Group integration.
  • ↑Fastest-growing export channel: Q3 export contracts $2.8M across Israel, Australia, Germany.
  • ↑Six straight quarters of positive cash flow, $5.4M total inflows.
  • ↑Declared $0.28/share dividend at a 59% payout ratio, boosting shareholder returns.
  • ↑Strong earnings yield and leverage profiles suggest attractive relative value.

Bear says

  • ↓Recreational sales decline noted by management could hinder revenue momentum.
  • ↓Cash reserves fell from $6.8M to $0.8M post-acquisitions, raising liquidity concerns.
  • ↓Corporate overhead rose 75% YoY; gross margin 34% still under price pressure.
  • ↓Negative profitability factor highlights inefficiency converting revenue into profit.
  • ↓Export strategy faces regulatory uncertainty in key overseas markets.
  • ↓High interest-rate sensitivity and low institutional ownership add downside risk.

Investment themes with AVNT

High Dividend Yield↓ -0.51%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q4 2022 · Mgmt. Guidance

Updated 09-13-2026bullish

Transcript signals

Bull points

  • Fiscal 2022 was a record year for Avon as we continue to demonstrate our ability to scale, innovate, and deliver significant growth while many in the industry are contracting.
  • The acquisition closed earlier this month and is expected to significantly enhance our cultivation capabilities with an increase in facility square footage to approximately 185,000 square feet, resulting in a 60% increase in our annual production capacity for the company.
  • We completed nine export shipments of approximately 1,284 kilograms of cannabis to Israel and Australia, contributing approximately $5 million in sales.

Bear points

  • Our net loss from operations was 8.5 million this year compared to 5.4 million last year, and this increased loss is primarily due to non-cash items such as the fair value changes on biological assets, share-based compensation, and amortization.
  • we also reported adjusted net loss of $0.3 million for the quarter, which is an increase in loss over Q3.
Read full transcript analysis ›